- Home
- ACIU vs FRST Comparison
ACIU vs FRST Comparison
Compare ACIU & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FRST
- Stock Information
- Founded
- ACIU 2003
- FRST 2004
- Country
- ACIU Switzerland
- FRST United States
- Employees
- ACIU N/A
- FRST N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FRST Major Banks
- Sector
- ACIU Health Care
- FRST Finance
- Exchange
- ACIU Nasdaq
- FRST Nasdaq
- Market Cap
- ACIU 189.1M
- FRST 220.5M
- IPO Year
- ACIU 2016
- FRST 2006
- Fundamental
- Price
- ACIU $2.07
- FRST $11.29
- Analyst Decision
- ACIU Strong Buy
- FRST Buy
- Analyst Count
- ACIU 1
- FRST 1
- Target Price
- ACIU $12.00
- FRST $420.00
- AVG Volume (30 Days)
- ACIU 139.5K
- FRST 86.2K
- Earning Date
- ACIU 08-05-2025
- FRST 07-24-2025
- Dividend Yield
- ACIU N/A
- FRST 3.54%
- EPS Growth
- ACIU N/A
- FRST N/A
- EPS
- ACIU N/A
- FRST 0.16
- Revenue
- ACIU $32,014,254.00
- FRST $125,133,000.00
- Revenue This Year
- ACIU N/A
- FRST $21.33
- Revenue Next Year
- ACIU $533.21
- FRST $12.77
- P/E Ratio
- ACIU N/A
- FRST $70.32
- Revenue Growth
- ACIU 91.20
- FRST 22.34
- 52 Week Low
- ACIU $1.43
- FRST $7.59
- 52 Week High
- ACIU $4.26
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- ACIU 56.20
- FRST 76.28
- Support Level
- ACIU $1.65
- FRST $10.40
- Resistance Level
- ACIU $2.17
- FRST $11.16
- Average True Range (ATR)
- ACIU 0.17
- FRST 0.22
- MACD
- ACIU -0.01
- FRST 0.08
- Stochastic Oscillator
- ACIU 70.37
- FRST 97.33
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit.